SMAD3 and Myocardial fibrosis: In the present study, we clarified that TRIM33 attenuated Ang II–induced myocardial fibrosis in vivo and in vitro by mediating TGF-β1/Smad3/4 signaling and that the effect of TRIM33 was regulated by HSPB5.